{
 "id": "1180018",
 "text": "CT-388 is a dual GLP-1 receptor agonist, and GIP receptor agonist and modulator, with little to no beta-arrestin coupling at either receptor. It is made to be given once a week by injection. The drug is made by the pharmaceutical companies Roche (Swiss) and Genentech (American). * * * ==Research== In a 24-week trial, participants averaged 18.8% placebo adjusted weight loss. ==References== Category:Chemicals",
 "title": "CT-388"
}